We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target of ...

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

We recently published a list of These 10 Firms Topped Wednesday’s Trading. In this article, we are going to take a look at ...

Tempus AI Inc (NASDAQ:TEM) shares closed up 14.5% following the announcement of expanded strategic partnerships with ...

With the stock market in rally mode, there are more pockets of strength than there have been in a while. Among the winners ...

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this ...